These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evolution of serum antibodies against different classes of murine cytomegalovirus--induced antigens and virus isolation following a primary infection. Coppolecchia P; Furlini G; Re MC; Landini MP Microbiologica; 1983 Apr; 6(2):175-9. PubMed ID: 6306403 [TBL] [Abstract][Full Text] [Related]
4. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection. Gönczöl E; Danczig E; Boldogh I; Tóth T; Váczi L Acta Microbiol Hung; 1985; 32(1):39-47. PubMed ID: 2994350 [TBL] [Abstract][Full Text] [Related]
5. Latent infection of mouse cells with human cytomegalovirus. Boldogh I; Gönczöl E; Gärtner L; Vaczi L; Michelson S Bull Cancer; 1976; 63(3):411-6. PubMed ID: 187270 [TBL] [Abstract][Full Text] [Related]
6. Replication of human cytomegalovirus in severe combined immunodeficient mice implanted with human retinal tissue. Bidanset DJ; Rybak RJ; Hartline CB; Kern ER J Infect Dis; 2001 Jul; 184(2):192-5. PubMed ID: 11424017 [TBL] [Abstract][Full Text] [Related]
7. Virus studies in the treatment of congenital cytomegalovirus infections by cytosine arabinoside. Emödi G; Sartorius J; Just M; Rohner F; Bühler U Helv Paediatr Acta; 1972 Dec; 27(6):557-64. PubMed ID: 4346254 [No Abstract] [Full Text] [Related]
8. The effect of cytosine-arabinoside on the multiplication of cytomegalovirus and on the formation of virus-induced intracellular antigens. Váczi L; Gönczöl E Acta Virol; 1973 May; 17(3):189-95. PubMed ID: 4147136 [No Abstract] [Full Text] [Related]
9. Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide. Estlin EJ; Yule SM; Lowis SP Cancer Treat Rev; 2001 Dec; 27(6):339-50. PubMed ID: 11908927 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of prednisolone and azathioprine on the development of human cytomegalovirus replication post liver transplantation. Nebbia G; Mattes FM; Sabin CA; Samonakis D; Rolando N; Burroughs AK; Emery VC Transplantation; 2007 Sep; 84(5):605-10. PubMed ID: 17876273 [TBL] [Abstract][Full Text] [Related]
11. Effects of IL-12 on the response and susceptibility to experimental viral infections. Orange JS; Wolf SF; Biron CA J Immunol; 1994 Feb; 152(3):1253-64. PubMed ID: 7905500 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of reactivated latent murine cytomegalovirus infection. Shanley JD; Jordan MC; Cook ML; Stevens JG Am J Pathol; 1979 Apr; 95(1):67-80. PubMed ID: 219700 [TBL] [Abstract][Full Text] [Related]
14. Immunological study of cytomegalovirus complement-fixing antibodies in the population of the CSR. Seeman J J Hyg Epidemiol Microbiol Immunol; 1976; 20(4):489-96. PubMed ID: 192796 [TBL] [Abstract][Full Text] [Related]
15. Immunosuppression reactivates and disseminates latent murine cytomegalovirus. Jordan MC; Shanley JD; Stevens JG J Gen Virol; 1977 Nov; 37(2):419-23. PubMed ID: 200714 [TBL] [Abstract][Full Text] [Related]
16. Specific cellular unreactivity during cytomegalovirus infection in man. Fiorilli M; Panà A; Sirianni MC; Spaziani A; Aiuti F Boll Ist Sieroter Milan; 1978 Sep; 57(4):452-7. PubMed ID: 216376 [TBL] [Abstract][Full Text] [Related]
17. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection. Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983 [TBL] [Abstract][Full Text] [Related]
18. [Virus infections during immunosuppression (author's transl)]. Goetz O MMW Munch Med Wochenschr; 1976 Apr; 118(17):541-4. PubMed ID: 818526 [TBL] [Abstract][Full Text] [Related]
19. Heterotypic protective immune reactions in mice infected with distinct serotypes of human influenza virus. Floc'h F; Werner GH Ann Microbiol (Paris); 1978; 129(4):509-24. PubMed ID: 308787 [TBL] [Abstract][Full Text] [Related]
20. Use of temperature-sensitive mutants of mouse cytomegalovirus as vaccines. Sandford GR; Burns WH J Infect Dis; 1988 Sep; 158(3):596-601. PubMed ID: 2842407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]